MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination. Photo: Roberto Garaycoa / Cubadebate.
–
The MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination, assesses the quality of Phase III of the vaccination candidates Soberana 02 and Abdala that are advancing in Havana, Santiago de Cuba, Granma and Guantánamo.
Listen here
– .
Related posts:
Johnson reveals his secret plan for the "maritime theft" of covid vaccines
Do you suffer from migraine? What you eat could be the cause.
The 30-30-30 Diet: Ultimate Guide to Foods and Weight Loss Results
more tests and mobile vaccination so that “no one misses activities” «La Capital de Mar del Plata ne...
